Epilepsy: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• NMDA 0
• mTOR 3
• SCN1A 6
• SCN2A 2
• HMGB1 0
• PPAR 0
• BDNF 1
• NLRP3 0
• TLR4 0
• NRF2 0
• PTEN 0
• AKT 0
• PI3K 0
• IDH 0
• GLP-1 0
• IL-1 1
• JAK 0
• GPX4 0
• AMPK 0
• CTNNB1 1
• MAPK 0
• APOE 0
• COX-2 0
• SGLT2 0
• SIRT1 0
• STING 0
• TNF 0
• ERK 1
• HIF-1 0
• STAT3 0
• TP53 0
• TREM2 0
• CGRP 0
• HDAC 0
• MAPT 0
• YAP 0
• APP 0
• CXCR4 0
• HSP90 0
• IL-6 0
• JNK 0
• MDM2 0
• NOTCH1 0
• NOTCH3 0
• PD-1 0
• PINK1 0
• AQP4 0
• AR 0
• B7-H3 0
• BACE1 0
• BCL-2 0
• BRAF 0
• BRD4 0
• CD47 0
• DMD 0
• DPP-4 0
• FGFR 0
• FTO 0
• G6PD 0
• GBA1 0

EU-13 is a filter, not a ranking: it only narrows the list.

6 of 6+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 8
• Organoids 13
• Mendelian Randomization Analysis 36
• CRISPR-Cas Systems 9
• Gene Expression Profiling 28
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 14
• Exome Sequencing 114
• Proteomics 23
• Metabolomics 23
• Mass Spectrometry 7
• Flow Cytometry 3
• Immunohistochemistry 21
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 67
• Magnetic Resonance Imaging 570
• Machine Learning 111
• Deep Learning 78
• Cohort Studies 312
• Genome-Wide Association Study 37

See which targets of this disease your abstract mentions, and go to the people working on them.